← Dashboard
Stock
DVA
DAVITA INC.Health CareHealth Care ServicesLatest close $1899 of 27 marquee funds currently hold1 CUSIP mapped
Current holders
9
27 funds tracked
Ever held
13
Current + past
New this quarter
1
Exited this quarter
0
Marquee-fund ownership over time
Aug 13, 2013May 15, 2018Aug 11, 2022May 15, 2026
Now
9
This quarter's activity
New positions opened
Positions exited
None.
Current holders
Sorted by tenure (longest first)| Fund | First disclosed | Held | Entry price | Latest close | Return on entry |
|---|---|---|---|---|---|
| Bridgewater Associates re-entered | Q3 2013 | 52Q | $57 | $189 | +230% |
| Berkshire Hathaway | Q3 2013 | 52Q | $57 | $189 | +234% |
| Renaissance Technologies re-entered | Q3 2024(8Q snapshot) | 7Q | $140 | $189 | +35% |
| Citadel Advisors | Q3 2024(8Q snapshot) | 7Q | $149 | $189 | +27% |
| Two Sigma Investments re-entered | Q3 2024(8Q snapshot) | 7Q | $149 | $189 | +27% |
| D.E. Shaw | Q3 2024(8Q snapshot) | 7Q | $149 | $189 | +27% |
| AQR Capital Management | Q3 2024(8Q snapshot) | 7Q | $149 | $189 | +27% |
| Millennium Management | Q3 2024(8Q snapshot) | 7Q | $149 | $189 | +27% |
| Point72 Asset Management re-entered | Q3 2024(8Q snapshot) | 7Q | $149 | $189 | +27% |
“Return on entry” is the price-only move from the fund's first disclosure to today — it ignores any adds, trims, or dividends. A fund that built its position over multiple quarters has a true cost basis somewhere between entry price and latest close; this figure is the upper bound.
Past holders
Funds that exited at some point| Fund | Last entry | Exited | Entry → Exit | Return |
|---|---|---|---|---|
| Maverick Capital 4× in & out | Q2 2024 | Q4 2025 | → $122 | -12% |
| Glenview Capital 3× in & out | Q2 2023 | Q3 2023 | → $107 | +10% |
| Viking Global Investors 4× in & out | Q1 2019 | Q4 2019 | → $69 | +19% |
| Lone Pine Capital 2× in & out | Q1 2015 | Q1 2016 | → $63 | -14% |
Insider activity
Form 4 — officers, directors, 10%+ ownersFiled within two business days of each transaction by anyone with material insider status at DAVITA INC.. Pair with the holders table above as a sanity check: heavy insider buying alongside marquee-fund accumulation is the strongest accumulation signal; heavy insider selling alongside fund exits is the strongest distribution signal.
Filings · last 30d
14
Filings · last 90d
31
Total on file
687
Recent SEC buffer
Most recent
May 28, 2026
30d / 90d windows measured from May 28, 2026 — the most recent Form 4 on file — not from today.
- Form 40000927066-26-000088May 28, 2026
- Form 40000927066-26-000085May 18, 2026
- Form 40000927066-26-000084May 18, 2026
- Form 40000927066-26-000083May 18, 2026
- Form 40000927066-26-000082May 18, 2026
- Form 40000927066-26-000081May 18, 2026
- Form 40000927066-26-000080May 18, 2026
- Form 40000927066-26-000079May 18, 2026
- Form 40000927066-26-000078May 18, 2026
- Form 40000927066-26-000069May 18, 2026
- Form 40000927066-26-000067May 13, 2026
- Form 40000927066-26-000065May 11, 2026
- Form 40000927066-26-000064May 8, 2026
- Form 40001193125-26-207021May 5, 2026
- Form 40000927066-26-000046Mar 17, 2026
Showing 15 of 687 recent Form 4 filings. Browse all on EDGAR ↗
Fundamentals
XBRL · DAVITA INC.Annual figures sourced directly from DAVITA INC.'s 10-K / 10-Q filings via SEC EDGAR XBRL. Latest fiscal year and the year-over-year change, with up to ten years of history.
Revenue
$13.64B
FY2025+6% YoY
Net income
$746.8M
FY2025-20% YoY
EPS (diluted)
$9.84
FY2025-8% YoY
Free cash flow(?)
$1.31B
FY2025-11% YoY
Recent SEC filings
10-K · 10-Q · 8-K · 13D/G · proxyThe most recent material filings for DAVITA INC. — earnings, material events, ownership disclosures, proxy statements. Form 4 insider activity is shown in the panel above.
- 8-KCURRENT REPORTJun 8, 2026
- 10-QQuarterly reportMay 5, 2026
- 8-KMaterial eventMay 5, 2026
- DEF 14AProxy statementApr 22, 2026
- 10-KAnnual reportFeb 11, 2026
- 8-KMaterial eventFeb 2, 2026
- 8-KCURRENT REPORTNov 25, 2025
- 10-QQuarterly reportOct 29, 2025
- 8-KMaterial eventOct 29, 2025
- 8-KMaterial eventAug 20, 2025
- 10-QQuarterly reportAug 5, 2025
- 8-KMaterial eventAug 5, 2025
- 8-KMaterial eventJul 17, 2025
- 8-KMaterial eventJun 9, 2025
- 8-KCURRENT REPORTMay 23, 2025
Trade history
Every open→close lifecycle across tracked funds| Fund | Open date | Close date | Open price | Close price / current | Return |
|---|---|---|---|---|---|
| Point72 Asset Management | Q2 2026 | open | $200 | $194 | -3% |
| Two Sigma Investments | Q1 2026 | open | $150 | $194 | +29% |
| Renaissance Technologies | Q1 2026 | open | $150 | $194 | +30% |
| Citadel Advisors | Q3 2024 | open | $149 | $194 | +31% |
| Two Sigma Investments | Q3 2024 | Q2 2025 | $149 | $144 | -4% |
| D.E. Shaw | Q3 2024 | open | $149 | $194 | +31% |
| AQR Capital Management | Q3 2024 | open | $149 | $194 | +31% |
| Millennium Management | Q3 2024 | open | $149 | $194 | +31% |
| Point72 Asset Management | Q3 2024 | Q4 2024 | $149 | $154 | +4% |
| Renaissance Technologies | Q3 2024 | Q1 2025 | $140 | $177 | +26% |
| Maverick Capital | Q2 2024 | Q4 2025 | $138 | $122 | -12% |
| Glenview Capital | Q2 2023 | Q3 2023 | $97 | $107 | +10% |
| Maverick Capital | Q4 2022 | Q4 2023 | $72 | $92 | +28% |
| Bridgewater Associates | Q3 2021 | open | $130 | $189 | +45% |
| Glenview Capital | Q3 2020 | Q3 2022 | $82 | $92 | +11% |
| Bridgewater Associates | Q2 2020 | Q4 2020 | $78 | $111 | +41% |
| Maverick Capital | Q4 2019 | Q2 2022 | $69 | $100 | +45% |
| Glenview Capital | Q2 2019 | Q2 2020 | $50 | $79 | +58% |
| Viking Global Investors | Q1 2019 | Q4 2019 | $58 | $69 | +19% |
| Bridgewater Associates | Q4 2018 | Q1 2020 | $64 | $86 | +34% |
| Bridgewater Associates | Q2 2018 | Q3 2018 | $66 | $72 | +9% |
| Maverick Capital | Q2 2018 | Q3 2018 | $66 | $72 | +9% |
| Viking Global Investors | Q2 2017 | Q3 2017 | $66 | $57 | -14% |
| Viking Global Investors | Q2 2016 | Q4 2016 | $77 | $61 | -21% |
| Bridgewater Associates | Q1 2016 | Q1 2018 | $63 | $74 | +18% |
| Lone Pine Capital | Q1 2015 | Q1 2016 | $73 | $63 | -14% |
| Viking Global Investors | Q1 2014 | Q1 2016 | $66 | $63 | -6% |
| Lone Pine Capital | Q4 2013 | Q3 2014 | $59 | $73 | +25% |
| Berkshire Hathaway | Q3 2013 | open | $57 | $189 | +234% |
| Bridgewater Associates | Q3 2013 | Q4 2015 | $57 | $73 | +28% |
Caveats
- Covers only the 27 marquee funds tracked here, not the full institutional universe. A “0 holders” reading does not mean unowned.
- Heavy funds (Renaissance Technologies, Citadel Advisors, Soros Fund Management, Two Sigma Investments, D.E. Shaw, AQR Capital Management, Millennium Management, Point72 Asset Management) use 8-quarter snapshots, so their pre-2024 history is missing.
- “Current” reflects each fund's most recent 13F — filings lag the actual trade by up to 45 days; positions shown may have changed since.
- Cost = price at the entry filing date. Re-entered positions show the most recent open lot.
- Options, ADRs, and unmapped CUSIPs are excluded from the follower-backtest pipeline that produces these snapshots, so certain holding types won't appear here.